"Vero Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CELL LINE derived from the kidney of the African green (vervet) monkey, (CERCOPITHECUS AETHIOPS) used primarily in virus replication studies and plaque assays.
| Descriptor ID |
D014709
|
| MeSH Number(s) |
A11.251.210.955 A11.436.955
|
| Concept/Terms |
Vero Cells- Vero Cells
- Cell, Vero
- Cells, Vero
- Vero Cell
|
Below are MeSH descriptors whose meaning is more general than "Vero Cells".
Below are MeSH descriptors whose meaning is more specific than "Vero Cells".
This graph shows the total number of publications written about "Vero Cells" by people in this website by year, and whether "Vero Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 3 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 9 | 9 |
| 2004 | 0 | 29 | 29 |
| 2005 | 2 | 41 | 43 |
| 2006 | 0 | 28 | 28 |
| 2007 | 0 | 18 | 18 |
| 2008 | 0 | 13 | 13 |
| 2009 | 0 | 7 | 7 |
| 2010 | 0 | 9 | 9 |
| 2011 | 0 | 9 | 9 |
| 2012 | 0 | 6 | 6 |
| 2013 | 0 | 11 | 11 |
| 2014 | 0 | 15 | 15 |
| 2015 | 0 | 13 | 13 |
| 2016 | 0 | 14 | 14 |
| 2017 | 0 | 102 | 102 |
| 2018 | 0 | 94 | 94 |
| 2019 | 1 | 42 | 43 |
| 2020 | 0 | 229 | 229 |
| 2021 | 1 | 243 | 244 |
To return to the timeline, click here.
Below are the most recent publications written about "Vero Cells" by people in Profiles.
-
An easy method for developing fusion enabled SARS-CoV2 virus fusion mimic (SCFM), bypassing the need of Bio Safety Level (BSL) facility. Bioengineered. 2021 12; 12(1):4407-4419.
-
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19. Emerg Microbes Infect. 2021 Dec; 10(1):1574-1588.
-
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion. J Infect Dis. 2021 09 17; 224(6):989-994.
-
Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1. Proc Natl Acad Sci U S A. 2021 09 14; 118(37).
-
Neutralization of alpha, gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies. J Med Virol. 2022 01; 94(1):399-403.
-
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
-
Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
-
New Pyrazine Conjugates: Synthesis, Computational Studies, and Antiviral Properties against SARS-CoV-2. ChemMedChem. 2021 11 19; 16(22):3418-3427.
-
Ethacridine inhibits SARS-CoV-2 by inactivating viral particles. PLoS Pathog. 2021 09; 17(9):e1009898.
-
SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling. Biochim Biophys Acta Mol Basis Dis. 2021 12 01; 1867(12):166260.